Activity Information

This session in the ACR Convergence 2024 Replay series is a recorded webinar that took place on June 12, 2025.  The series features popular scientific sessions followed by a Q&A with the faculty.

This session features dermatologists with expertise in diseases in skin of color and systemic sclerosis and its mimics.  It includes updates in the management of psoriasis from a dermatologist’s perspective, which may differ from the way we approach patients with musculoskeletal involvement.

Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.

Target Audience

Rheumatologists, dermatologists, and rheumatology interprofessionals who care for patients with rheumatic diseases.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Recognize how rheumatic disease appears in skin of color and recognize the challenges that lead to disparities in this patient population as they pertain to skin disease
• Differentiate the skin manifestations of systemic sclerosis and its mimics and describe therapies for each
• Delineate the dermatologist’s perspective for psoriasis management

CE & MOC Information

CME

ACCME Accreditation Statement

AMA Designation Statement

The American College of Rheumatology designates this Enduring Activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.

CME credit must be claimed by July 9, 2028, at 11:59 PM ET.

Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. ACR Convergence Replay: More Than Skin Deep: What Rheumatologists Should Know About the Skin Financial Relationship Disclosures

Acknowledgement of Commercial Support

No commercial support was provided for this activity.

Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.